Skip to content
Resources > Reports

AlphaSense Market Report by TrustRadius

In the high-stakes world of financial and market research, fragmented information wastes time and costs opportunities. Traditional market intelligence platforms are cumbersome, making it challenging to access critical insights when they matter most.

As a 2025 Buyer’s Choice Award winner on TrustRadius, AlphaSense delivers a seamless and comprehensive research experience, blending cutting-edge AI with an intuitive interface designed for quick, data-driven decision-making.

Read the TrustRadius report to learn why top financial firms and corporations choose AlphaSense, including:

  • Vast Data Access:Consolidates a huge library of information into one easy-to-use platform.
  • AI-Driven Efficiency:Sentiment analysis and real-time alerts help surface critical insights faster.
  • Intuitive Interface:No complex training required—just quick, actionable results.

Proven Success:

  • 100% of TrustRadius reviewers would buy AlphaSense again.
  • 99% say it delivers excellent value for the price.

Explore more

Enterprise Software: Assessing AI Adoption Trends

Generative AI is moving from isolated pilots to full-scale deployments, with adoption accelerating in areas like software development and IT service management.
Title slide: Enterprise Software: Assessing AI Adoption Trends, by Michelle Brophy and Sean Carmichael, featuring a computer illustration and AI logo.

From Promise to Performance: How AI Will Evolve in 2026

2025 was the year generative AI grew up, shifting from isolated experiments to integrated systems. What also emerged was a clearer picture of how AI will continue to mature in 2026.
Title slide: From Promise to Performance: How AI Will Evolve in 2026 by Sarah Hoffman, Director of AI Thought Leadership, with abstract tech graphics.

Most-Favored-Nation Policy: Implications for European Drug Launches

The U.S. shift toward most-favored-nation (MFN) drug pricing is forcing pharmaceutical firms to rethink their pricing models and launch strategies in Europe.
U.S. Most-Favored-Nation Drug Pricing Policy: What Does It Mean for Europe? by Sara Mallatt and Sean Carmichael, with a stylized map of Europe.

Transform intelligence
into advantage

Develop bold strategies, seize opportunities,
and lead with clarity and confidence.